Company-wide revenue
Reported revenue in 2021 ¥55.76B Reported revenue in 2025 ¥76.93B
- growth amount
- +¥21.17B
- growth annualized
- +8.4%
- growth total
- +38.0%
Japanese company profile · 4368
FUSO CHEMICAL CO.,LTD.
In its FY2025 public filing, FUSO CHEMICAL CO.,LTD. reports Life Sciences Business, Electronic Materials Business. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 扶桑化学工業株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
FUSO CHEMICAL CO.,LTD.'s largest reported business by revenue in FY2025 was Electronic Materials Business.
The business with the highest reported segment profit in FY2025 was Electronic Materials Business.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Electronic Materials Business | ¥41.51B ↗ | 54.0% | ¥15.93B ↗ |
| Life Sciences Business | ¥35.41B ↗ | 46.0% | ¥5.31B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Life Sciences Business
- ライフサイエンス事業
- Electronic Materials Business
- 電子材料事業
- Business label unavailable in English
- 電子材料および機能性化学品事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Life Sciences Business
- ライフサイエンス事業
- Electronic Materials Business
- 電子材料事業
- Business label unavailable in English
- 電子材料および機能性化学品事業
- Sales
- 売上高
- Operating profit
- 営業利益
What is growing?
What is growing?
Business revenue growth
Life Sciences Business
Reported revenue in 2021 ¥31.43B Reported revenue in 2025 ¥35.41B
- growth amount
- +¥3.98B
- growth annualized
- +3.0%
- growth total
- +12.7%
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YEIS
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.